David O. Watson

General Counsel at Apellis Pharmaceuticals · 13 reported transactions in 1 company · latest trade Jan 22, 2026

Their trades


Apellis PharmaceuticalsAPLS	Sold $170.5K · 7,832 shares	Jan 22, 2026
Apellis PharmaceuticalsAPLS	Sold $49K · 2,475 shares	Jan 20, 2026
Apellis PharmaceuticalsAPLS	Sold $128.2K · 5,780 shares	Jan 13, 2026
Apellis PharmaceuticalsAPLS	Sold $122.4K · 5,000 shares	Dec 16, 2025
Apellis PharmaceuticalsAPLS	Sold $100.3K · 5,000 shares	Nov 17, 2025
Apellis PharmaceuticalsAPLS	Sold $126.1K · 5,000 shares	Oct 16, 2025
Apellis PharmaceuticalsAPLS	Sold $121.7K · 5,000 shares	Sep 16, 2025
Apellis PharmaceuticalsAPLS	Sold $523.4K · 20,000 shares	Sep 10, 2025

Jan 22, 2026 · APLS

$170.5K

Jan 20, 2026 · APLS

$49K

Jan 13, 2026 · APLS

$128.2K

Dec 16, 2025 · APLS

$122.4K

Nov 17, 2025 · APLS

$100.3K

Oct 16, 2025 · APLS

$126.1K

Sep 16, 2025 · APLS

$121.7K

Sep 10, 2025 · APLS

$523.4K

Newest 10 of 13 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

General Counsel at Apellis Pharmaceuticals · 13 reported transactions in 1 company · latest trade Jan 22, 2026


Apellis PharmaceuticalsAPLS	Sold $170.5K · 7,832 shares	Jan 22, 2026
Apellis PharmaceuticalsAPLS	Sold $49K · 2,475 shares	Jan 20, 2026
Apellis PharmaceuticalsAPLS	Sold $128.2K · 5,780 shares	Jan 13, 2026
Apellis PharmaceuticalsAPLS	Sold $122.4K · 5,000 shares	Dec 16, 2025
Apellis PharmaceuticalsAPLS	Sold $100.3K · 5,000 shares	Nov 17, 2025
Apellis PharmaceuticalsAPLS	Sold $126.1K · 5,000 shares	Oct 16, 2025
Apellis PharmaceuticalsAPLS	Sold $121.7K · 5,000 shares	Sep 16, 2025
Apellis PharmaceuticalsAPLS	Sold $523.4K · 20,000 shares	Sep 10, 2025